NCT00040222
- Conditions
- Adnexal Diseases, BRCA1-associate Malignancies, BRCA2-associated Malignancies, +42 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Explore clinical trials studying Hamartoma Syndrome, Multiple. Study availability and eligibility vary by location and protocol.
NCT00040222
NCT04094675
NCT02991807
NCT05671107
NCT00600275
NCT00620594
NCT03495089
NCT00971789